NILOTINIB, ASCIMINIB HYDROCHLORIDE, NILOTINIB, NILOTINIB
CABL001J12302
Phase 3 small_molecule active
Quick answer
NILOTINIB, ASCIMINIB HYDROCHLORIDE, NILOTINIB, NILOTINIB for Chronic Myeloid Leukemia is a Phase 3 program (small_molecule) at Novartis Ophthalmics Europe with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Novartis Ophthalmics Europe
- Indication
- Chronic Myeloid Leukemia
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- active